BioAtla, Inc. (BCAB)
NASDAQ·Healthcare·Biotechnology
$4.47
-0.94%
Mkt Cap $5.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $700.00K | $2.00M | +185.71% | -$12.00 | -$8.00 | +33.33% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.31 | -$0.27 | +12.90% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.29 | -$0.31 | -6.90% | — | — |
| Q2 2025 May 6, 2025 | — | — | — | -$0.28 | -$0.29 | -3.57% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.40 | -$0.32 | +20.00% | — | — |
| Q4 2024 Nov 7, 2024 | — | $11.00M | — | -$0.34 | -$0.22 | +35.29% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.45 | -$0.44 | +2.22% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.57 | -$0.48 | +15.79% | — | — |
| Q1 2024 Mar 26, 2024 | $15.00M | — | — | -$0.79 | -$0.56 | +29.11% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.77 | -$0.70 | +9.09% | — | — |
| Q3 2023 Aug 1, 2023 | — | — | — | -$0.64 | -$0.75 | -17.19% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.66 | -$0.58 | +12.12% | — | — |
| Q1 2023 Mar 23, 2023 | $1.50M | — | — | -$0.74 | -$0.63 | +14.86% | — | — |
| Q4 2022 Nov 4, 2022 | $466.67K | — | — | -$0.77 | -$0.69 | +10.39% | — | — |
| Q3 2022 Aug 9, 2022 | $333.33K | — | — | -$0.70 | -$0.77 | -10.00% | — | — |
| Q2 2022 May 5, 2022 | $250.00K | — | — | -$0.69 | -$0.65 | +5.80% | — | — |
| Q1 2022 Mar 1, 2022 | $4.60M | $250.00K | -94.57% | -$0.58 | -$0.63 | -8.60% | — | — |
| Q4 2021 Nov 15, 2021 | $4.60M | — | — | -$0.64 | -$0.68 | -5.57% | — | — |
| Q3 2021 Aug 13, 2021 | $243.08K | $250.00K | +2.85% | -$0.56 | -$0.90 | -60.71% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | -$0.52 | -$0.56 | -7.69% | — | — |